Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Same-day discharge surgery for robot-assisted radical prostatectomy in the era of ERAS and prehabilitation pathways: a contemporary, comparative, feasibility study.

Ploussard G, Almeras C, Beauval JB, Gautier JR, Loison G, Salin A, Tollon C.

World J Urol. 2020 Feb 17. doi: 10.1007/s00345-020-03119-w. [Epub ahead of print]

PMID:
32065277
2.

Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction.

Ploussard G, Beauval JB, Renard-Penna R, Lesourd M, Manceau C, Almeras C, Gautier JR, Loison G, Portalez D, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M.

J Clin Med. 2020 Jan 15;9(1). pii: E225. doi: 10.3390/jcm9010225.

3.

Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features.

Roumiguie M, Lesourd M, Zgheib J, Tollon C, Salin A, Alméras C, Doumerc N, Thoulouzan M, Soulié M, Gautier JR, Loison G, Assoun J, Vacher A, Aziza R, Malavaud B, Beauval JB, Ploussard G.

Urol Oncol. 2020 Jan 13. pii: S1078-1439(19)30505-8. doi: 10.1016/j.urolonc.2019.12.018. [Epub ahead of print]

PMID:
31948932
4.

Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

Urology. 2020 Mar;137:126-132. doi: 10.1016/j.urology.2019.10.039. Epub 2019 Dec 30.

PMID:
31899229
5.

Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery.

Ploussard G, Manceau C, Beauval JB, Lesourd M, Almeras C, Gautier JR, Loison G, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M.

World J Urol. 2019 Dec 14. doi: 10.1007/s00345-019-03053-6. [Epub ahead of print]

PMID:
31838560
6.

Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study.

Ploussard G, Beauval JB, Lesourd M, Manceau C, Almeras C, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

World J Urol. 2019 Oct 14. doi: 10.1007/s00345-019-02973-7. [Epub ahead of print]

PMID:
31612251
7.

Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

J Urol. 2019 Dec;202(6):1182-1187. doi: 10.1097/JU.0000000000000418. Epub 2019 Jun 27.

PMID:
31246548
8.

Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

World J Urol. 2020 Mar;38(3):663-671. doi: 10.1007/s00345-019-02848-x. Epub 2019 Jun 13.

PMID:
31197523
9.

[Double J stent removal's cost estimate using a re-sterilizable fibroscope in a French private structure].

Almeras C, Loison G, Tollon C, Gautier JR, Badoc C, Cid E, Sabatier R, Zanoun L, Brudo L.

Prog Urol. 2017 Dec;27(16):1031-1035. doi: 10.1016/j.purol.2017.07.240. Epub 2017 Aug 30. French.

PMID:
28869172
10.

Compliance with clothing regulations and traffic flow in the operating room: a multi-centre study of staff discipline during surgical procedures.

Loison G, Troughton R, Raymond F, Lepelletier D, Lucet JC, Avril C, Birgand G; ARLIN Working Group.

J Hosp Infect. 2017 Jul;96(3):281-285. doi: 10.1016/j.jhin.2017.03.026. Epub 2017 Mar 31.

PMID:
28502482
11.

Differential Virtual Screening (DVS) with Active and Inactive Molecular Models for Finding and Profiling GPCR Modulators: Case of the CCK1 Receptor.

Diaz C, Leplatois P, Angelloz-Nicoud P, Lecomte M, Josse A, Delpech M, Pecceu F, Loison G, Shire D, Pascal M, Ferrara P, Ferran E.

Mol Inform. 2011 Apr 18;30(4):345-58. doi: 10.1002/minf.201000180. Epub 2011 Apr 1.

PMID:
27466951
12.

[Evaluation of sexuality and erectile function of candidates for radical prostatectomy].

Long JA, Lebret T, Saporta F, Hervé JM, Lugagne PM, Poulain JE, Yonneau L, Loison G, Orsoni JL, Botto H.

Prog Urol. 2006 Sep;16(4):450-6. French.

PMID:
17069038
13.

Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.

Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker MO, Gattegno B, Richard F, Cussenot O.

Urology. 2006 Jun;67(6):1181-7.

PMID:
16765178
14.

rdlA, a new gene encoding a rhodanese-like protein in Halanaerobium congolense and other thiosulfate-reducing anaerobes.

Ravot G, Casalot L, Ollivier B, Loison G, Magot M.

Res Microbiol. 2005 Dec;156(10):1031-8. Epub 2005 Jul 13.

PMID:
16085393
15.

[Ureterolysis: technique, indications].

Loison G, Almeras C, Chartier-Kastler E.

Ann Urol (Paris). 2005 Feb;39(1):1-9. Review. French.

PMID:
15830549
16.

Identification and pharmacological characterization of SRBP-2: a novel SR31747A-binding protein.

Vidal H, Mondesert G, Galiègue S, Carrière D, Dupuy PH, Carayon P, Combes T, Bribes E, Simony-Lafontaine J, Kramar A, Loison G, Casellas P.

Cancer Res. 2003 Aug 15;63(16):4809-18.

17.

A DNA microarray-based approach to elucidate the effects of the immunosuppressant SR31747A on gene expression in Saccharomyces cerevisiae.

Cinato E, Péléraux A, Silve S, Galiègue S, Dhers C, Picard C, Jbilo O, Loison G, Casellas P.

Gene Expr. 2002;10(5-6):213-30.

18.

Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (siemens-multiline).

Lebret T, Loison G, Hervé JM, Mc Eleny KR, Lugagne PM, Yonneau L, Orsoni JL, Saporta F, Butreau M, Botto H.

Urology. 2002 May;59(5):657-61.

PMID:
11992835
19.

Neurotensin induces mating in Saccharomyces cerevisiae cells that express human neurotensin receptor type 1 in place of the endogenous pheromone receptor.

Leplatois P, Josse A, Guillemot M, Febvre M, Vita N, Ferrara P, Loison G.

Eur J Biochem. 2001 Sep;268(18):4860-7.

20.

Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and sphingolipids.

Tvrdik P, Westerberg R, Silve S, Asadi A, Jakobsson A, Cannon B, Loison G, Jacobsson A.

J Cell Biol. 2000 May 1;149(3):707-18.

21.

Sterol metabolism and ERG2 gene regulation in the yeast Saccharomyces cerevisiae.

Soustre I, Dupuy PH, Silve S, Karst F, Loison G.

FEBS Lett. 2000 Mar 24;470(2):102-6.

22.

Colocalization of sterol isomerase and sigma(1) receptor at endoplasmic reticulum and nuclear envelope level.

Dussossoy D, Carayon P, Belugou S, Feraut D, Bord A, Goubet C, Roque C, Vidal H, Combes T, Loison G, Casellas P.

Eur J Biochem. 1999 Jul;263(2):377-86.

23.

Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step.

Labit-Le Bouteiller C, Jamme MF, David M, Silve S, Lanau C, Dhers C, Picard C, Rahier A, Taton M, Loison G, Caput D, Ferrara P, Lupker J.

Eur J Biochem. 1998 Sep 1;256(2):342-9.

24.

Human lamin B receptor exhibits sterol C14-reductase activity in Saccharomyces cerevisiae.

Silve S, Dupuy PH, Ferrara P, Loison G.

Biochim Biophys Acta. 1998 Jun 15;1392(2-3):233-44.

PMID:
9630650
25.

Both the immunosuppressant SR31747 and the antiestrogen tamoxifen bind to an emopamil-insensitive site of mammalian Delta8-Delta7 sterol isomerase.

Paul R, Silve S, De Nys N, Dupuy PH, Bouteiller CL, Rosenfeld J, Ferrara P, Le Fur G, Casellas P, Loison G.

J Pharmacol Exp Ther. 1998 Jun;285(3):1296-302.

PMID:
9618436
27.

Purification and characterization of the human SR 31747A-binding protein. A nuclear membrane protein related to yeast sterol isomerase.

Jbilo O, Vidal H, Paul R, De Nys N, Bensaid M, Silve S, Carayon P, Davi D, Galiègue S, Bourrié B, Guillemot JC, Ferrara P, Loison G, Maffrand JP, Le Fur G, Casellas P.

J Biol Chem. 1997 Oct 24;272(43):27107-15.

28.

N-acetyl-heparosan lyase of Escherichia coli K5: gene cloning and expression.

Legoux R, Lelong P, Jourde C, Feuillerat C, Capdevielle J, Sure V, Ferran E, Kaghad M, Delpech B, Shire D, Ferrara P, Loison G, Salomé M.

J Bacteriol. 1996 Dec;178(24):7260-4.

29.

Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits delta8-delta7 sterol isomerase activity in yeast.

Silve S, Dupuy PH, Labit-Lebouteiller C, Kaghad M, Chalon P, Rahier A, Taton M, Lupker J, Shire D, Loison G.

J Biol Chem. 1996 Sep 13;271(37):22434-40.

30.

The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae.

Silve S, Leplatois P, Josse A, Dupuy PH, Lanau C, Kaghad M, Dhers C, Picard C, Rahier A, Taton M, Le Fur G, Caput D, Ferrara P, Loison G.

Mol Cell Biol. 1996 Jun;16(6):2719-27.

31.

Cloning and characterization of the eapB and eapC genes of Cryphonectria parasitica encoding two new acid proteinases, and disruption of eapC.

Jara P, Gilbert S, Delmas P, Guillemot JC, Kaghad M, Ferrara P, Loison G.

Mol Gen Genet. 1996 Jan 15;250(1):97-105.

PMID:
8569693
32.
33.

Self-cloning in filamentous fungi: application to the construction of endothiapepsin overproducers in Cryphonectria parasitica.

Jara P, Delmas P, Razanamparany V, Olsen L, Dupin P, Bayol A, Bégueret J, Loison G.

J Biotechnol. 1995 Jun 1;40(2):111-20.

PMID:
7612240
34.

High-level production of a human membrane protein in yeast: the peripheral-type benzodiazepine receptor.

Joseph-Liauzun E, Farges R, Le Fur G, Ferrara P, Loison G.

Gene. 1995 Apr 3;155(2):195-9.

PMID:
7721090
35.

Molecular basis for the different binding properties of benzodiazepines to human and bovine peripheral-type benzodiazepine receptors.

Farges R, Joseph-Liauzun E, Shire D, Caput D, Le Fur G, Loison G, Ferrara P.

FEBS Lett. 1993 Dec 13;335(3):305-8.

36.

Genetic improvements of an industrial strain of Aspergillus flavus for urate oxidase production.

Chevalet L, Tiraby G, Cabane B, Loison G.

J Biotechnol. 1993 Feb;27(3):239-47.

PMID:
7763466
38.

Cloning and mutation of the gene encoding endothiapepsin from Cryphonectria parasitica.

Razanamparany V, Jara P, Legoux R, Delmas P, Msayeh F, Kaghad M, Loison G.

Curr Genet. 1992 May;21(6):455-61.

PMID:
1617734
39.

Transformation of Aspergillus flavus: construction of urate oxidase-deficient mutants by gene disruption.

Chevalet L, Tiraby G, Cabane B, Loison G.

Curr Genet. 1992 May;21(6):447-53.

PMID:
1617733
40.

Cloning and expression in Escherichia coli of the gene encoding Aspergillus flavus urate oxidase.

Legoux R, Delpech B, Dumont X, Guillemot JC, Ramond P, Shire D, Caput D, Ferrara P, Loison G.

J Biol Chem. 1992 Apr 25;267(12):8565-70.

41.

Expression and pharmacological characterization of the human peripheral-type benzodiazepine receptor in yeast.

Riond J, Leplatois P, Laurent P, Le Fur G, Caput D, Loison G, Ferrara P.

Eur J Pharmacol. 1991 Dec 12;208(4):307-12.

PMID:
1667758
42.

High level of expression of a protective antigen of schistosomes in Saccharomyces cerevisiae.

Loison G, Vidal A, Findeli A, Roitsch C, Balloul JM, Lemoine Y.

Yeast. 1989 Nov-Dec;5(6):497-507.

PMID:
2694678
43.

Production and evaluation of recombinant hirudin.

Courtney M, Loison G, Lemoine Y, Riehl-Bellon N, Degryse E, Brown SW, Cazenave JP, Defreyn G, Delebassee D, Bernat A, et al.

Semin Thromb Hemost. 1989 Jul;15(3):288-92. Review.

PMID:
2688101
44.

Purification and biochemical characterization of recombinant hirudin produced by Saccharomyces cerevisiae.

Riehl-Bellon N, Carvallo D, Acker M, Van Dorsselaer A, Marquet M, Loison G, Lemoine Y, Brown SW, Courtney M, Roitsch C.

Biochemistry. 1989 Apr 4;28(7):2941-9.

PMID:
2663064
45.

Activation of transcription of a yeast gene in E. coli by an IS5 element.

Jund R, Loison G.

Nature. 1982 Apr 15;296(5858):680-1. No abstract available.

PMID:
6280063
47.

Evidence for transcriptional regulation of dihydroorotic acid dehydrogenase in Saccharomyces cerevisiae.

Loison G, Jund R, Nguyen-Juilleret M, Lacroute F.

Curr Genet. 1981 May;3(2):119-23. doi: 10.1007/BF00365715.

PMID:
24190057
48.

Constitutive mutants for orotidine 5 phosphate decarboxylase and dihydroorotic acid dehydrogenase in Saccharomyces cerevisiae.

Loison G, Losson R, Lacroute F.

Curr Genet. 1980 Jul;2(1):39-44. doi: 10.1007/BF00445692.

PMID:
24189721
49.

Duboisia myoporoides: native antidote against ciguatera poisoning.

Dufva E, Loison G, Holmstedt B.

Toxicon. 1976;14(1):55-64. No abstract available.

PMID:
1258069
50.

[Value of the study of carbon monoxide transfer (method in apnea and method in the normal state) in coal miners].

Guerrin F, Robin H, Ramon D, Besson F, Boulenguez C, Loison G.

Lille Med. 1972 Oct;17(8):1144-53. French. No abstract available.

PMID:
4638139

Supplemental Content

Loading ...
Support Center